![]() |
市場調査レポート
商品コード
1666048
試験室用ろ過の市場規模、シェア、成長分析:製品タイプ別、技術別、エンドユーザー別、地域別 - 産業予測 2025~2032年Laboratory Filtration Market Size, Share, and Growth Analysis, By Product Type (Filtration Media, Filtration Assemblies), By Technology (Microfiltration, Ultrafiltration), By End User, By Region - Industry Forecast 2025-2032 |
||||||
|
試験室用ろ過の市場規模、シェア、成長分析:製品タイプ別、技術別、エンドユーザー別、地域別 - 産業予測 2025~2032年 |
出版日: 2025年02月26日
発行: SkyQuest
ページ情報: 英文 179 Pages
納期: 3~5営業日
|
試験室用ろ過市場規模は、2023年に45億米ドルと評価され、2024年の47億4,000万米ドルから2032年には71億6,000万米ドルに成長し、予測期間(2025-2032年)のCAGRは5.3%で成長する見通しです。
世界の試験室用ろ過市場は、超高純度ろ過技術の進歩や、下流工程における高性能ろ過製品への需要の高まりによって、大きな成長が見込まれています。Macherey-Nagel、GEヘルスケア、Hahnemuhleなどの主要メーカーは、ルーチンの定量分析および一般的なラボ用途に合わせた定性的な無灰濾紙を製造しています。精密濾過、ナノ濾過、限外濾過のような高度な濾過技術の利用が拡大していることも、市場の拡大をさらに後押ししています。さらに、ナノファイバー技術の急速な進歩や、製薬・バイオ医薬品分野でのろ過ソリューションの採用拡大が、力強い成長機会を生み出しています。厳しい規制基準の遵守と研究開発投資の増加は、優れたラボ用フィルターの必要性を高め、特に未開発の新興市場において業界の有望な見通しを確立しています。
Laboratory Filtration Market size was valued at USD 4.5 billion in 2023 and is poised to grow from USD 4.74 billion in 2024 to USD 7.16 billion by 2032, growing at a CAGR of 5.3% during the forecast period (2025-2032).
The global laboratory filtration market is poised for significant growth, driven by advancements in ultra-purification filtering techniques and heightened demand for high-performance filtration products in downstream processes. Key manufacturers such as Macherey-Nagel, GE Healthcare, and Hahnemuhle are producing qualitative, ashless filter papers tailored for routine quantitative analyses and general lab applications. The escalating use of sophisticated filtration technologies like microfiltration, nanofiltration, and ultrafiltration further supports market expansion. Additionally, rapid progress in nanofiber technology and increased adoption of filtration solutions in pharmaceutical and biopharmaceutical sectors create robust growth opportunities. Compliance with stringent regulatory standards and rising R&D investments enhance the need for superior laboratory filters, establishing a promising outlook for the industry, particularly in untapped, emerging markets.
Top-down and bottom-up approaches were used to estimate and validate the size of the Laboratory Filtration market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Laboratory Filtration Market Segments Analysis
Global Laboratory Filtration Market is segmented by Product Type, Technology, End User and region. Based on Product Type, the market is segmented into Filtration Media, Filtration Assemblies, Filtration Accessories and Others. Based on Technology, the market is segmented into Microfiltration, Ultrafiltration, Vacuum Filtration, Nano Filtration and Reverse Osmosis. Based on End User, the market is segmented into Pharmaceutical and Biotechnology Companies, Hospital and Diagnostic Laboratories, Food and Beverage Companies, Academic Institutes, Academic and Research Institutes and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Laboratory Filtration Market
The global laboratory filtration market is significantly propelled by the rising investments in research and development within the biopharmaceutical and biotechnology sectors. Filtration plays a vital role throughout the entire drug discovery, development, and manufacturing processes, particularly in ensuring drug purification and compliance with stringent regulatory standards. Additionally, the heightened focus on biologics, including monoclonal antibodies and vaccines, has intensified the need for advanced laboratory filtration technologies. As organizations strive to meet rigorous industry requirements and enhance product quality, the demand for innovative and efficient filtration solutions continues to grow, driving the market forward.
Restraints in the Laboratory Filtration Market
The Laboratory Filtration market faces significant restraints due to filter contamination and incompatibility with specific chemicals or samples, which can impede growth. These challenges often result in elevated operational costs, diminishing user confidence in the filtration technologies and potentially compromising the quality of results. Furthermore, ensuring compatibility and reliability is particularly troublesome for applications demanding exceptional precision and purity. As such, these ongoing issues could deter potential market players and users, ultimately affecting the overall development of the Laboratory Filtration sector. Addressing these concerns is essential for enhancing trust and performance in filtration technologies.
Market Trends of the Laboratory Filtration Market
The global laboratory filtration market is witnessing a significant trend driven by the rising demand for biopharmaceutical applications. As the production of biologics, vaccines, and cell therapies accelerates, the need for advanced filtration technologies becomes critical to ensure the purity and safety of these products. This demand is further amplified by the stringent regulatory standards that laboratories must adhere to, necessitating innovative filtration solutions. Consequently, the laboratory filtration market is poised for substantial growth, as companies seek to enhance their filtration processes to meet these evolving requirements, positioning themselves strategically in the competitive landscape of the biopharmaceutical sector.